We have previously shown that E1A reactivates the cell cycle in`irreversibly' growth arrested, terminally differentiated (TD) cells. The molecular events following E1A-mediated reactivation of TD skeletal muscle cells have been extensively investigated. However, the long-term fate of the reactivated cells has not been directly determined. In this paper, E1A is used to reactivate TD myotubes derived from established cell lines or primary myoblasts. We show that the reactivated muscle cells continue proliferating beyond the end of the first cell cycle and progress through at least a second one. Experiments performed with an inducible E1A/estrogen receptor chimera indicate that the reactivated cell cycle is self-sustained, since E1A is exclusively necessary to reactivate TD cells, but is dispensable for both the continuation of the first cycle and the progression into the following one. Finally, we report that E1A-mediated reactivation of muscle cells results in apoptotic cell death that can be delayed by the antiapoptotic, adenoviral E1B 55 kDa oncogene. Cell Death and Differentiation (2000) 7, 145 ± 154.
Introduction
Terminally differentiated cells are defined by specialized properties, which are the result of tissue-specific gene expression, associated with a physiologically irreversible growth arrest. Terminal differentiation characterizes the majority of the cells in an adult mammal. The inability of TD cells to replicate poses strategic problems to the organism. These cells must live as long as the organism itself, which requires extraordinary measures to ensure their survival. In addition, organs and systems devoid of stem cell compartments and whose parenchyma is composed exclusively of TD cells cannot renew their tissues by means of cell proliferation. This makes them especially vulnerable to irreplaceable cell loss caused by diseases or injuries. The ability to induce sustained proliferation of TD cells such as neurons, myocardiocytes, or endocrine cells would potentially have a major impact on the therapy of diseases and traumas of such organs.
One example of terminal differentiation is provided by skeletal muscle cells. 1 The differentiation process of these cells can be recapitulated in vitro. Primary as well as established myoblasts can be cultured extensively. Mitogen withdrawal starts the differentiation program, which begins with irreversible exit from the cell cycle (commitment). Postmitotic myoblasts then express muscle-specific genes, turning into mononucleated myocytes (biochemical differentiation). The final stage of skeletal muscle differentiation in vitro involves fusion of myocytes into multinucleated structures called myotubes (morphological differentiation). 1 It has been shown that a number of DNA tumor virus oncogenes are able to reactivate the cell cycle in TD cells. 2 ± 6 Adenoviruses bear the E1A oncogene, which shares this ability. 6 Adenoviruses are particularly well suited for cell cycle reactivation of TD cells, since they can infect almost all cell types 7, 8 across a wide range of species, 6 irrespective of the proliferation status of the cells. In fact, we and others have shown that adenovirus infection and the consequent E1A expression can reactivate a variety of TD cells, including myotubes, adipocytes, 6, 9 myocardiocytes, 10 and neurons (M Crescenzi, unpublished). E1A exerts such activity by activating genes normally expressed at the G1/S boundary. 11 By this mechanism, E1A in effect bypasses the cell cycle block that prevents TD myotubes from proceeding beyond mid-G1 phase upon mitogenic stimulation. 12 We have shown that E1A-reactivated myotubes undergo DNA replication, mitosis, and cytokinesis. 6, 9 However, the long-term fate of these cells has not been investigated in depth. Open questions include whether further cell cycles follow the first one, whether any fraction of the reactivated cells can survive indefinitely, and whether the activity of E1A is required to sustain the cell cycle or it is only needed to initiate it. All of these issues are relevant in view of potential therapeutic applications.
In this paper, we present evidence that TD skeletal muscle cells reactivated by E1A undergo more that one cell cycle. We show that the reactivated cells eventually die by apoptosis. Such outcome can be at least partially opposed by the antiapoptotic adenovirus E1B oncogene, which allows extended survival. Finally, making use of a conditional E1A chimera, we show that the cell cycle activated by the oncogene in myotubes is auto-maintained and, for its continuation, can dispense with the functional presence of E1A.
Results
Mitotic phenomena associated with cell cycle reactivation in myotubes
As already described, adenovirus-transduced E1A reactivates DNA synthesis in myotubes derived from established and primary myoblasts as well. While DNA synthesis occurs in E1A-reactivated myotubes irrespective of the presence of growth factors, the successive mitosis is greatly facilitated by serum. 6 Multinucleated myotubes undergo mitosis in a quasi-synchronous fashion. In elongated myotubes, whose nuclei are distributed over a long distance, mitosis often appears to initiate in a single nucleus. A mitotic`wave' then ensues, probably due to the diffusion of regulatory factors from one nucleus to the next. The result is the simultaneous presence of nuclei arranged in an orderly progression of mitotic stages (Figure 1a,b) . Mitosis is accompanied by cytokinesis, which may or may not result in successful cell division. As shown in Figure 1 , mitotic myotubes attempt to divide. Time-lapse videomicroscopy shows that myotubes sometimes separate into two or more fragments (Figure 2 ), sometimes stretch but eventually recollapse into a single structure. Most mitoses present morphological aberrations ranging from minor anomalies to gross disruption of nuclear organization. These include chromosomal displacement, incomplete chromatid disjunction, extensive micronucleation, and coalescence of multiple nuclei into a giant one (Figure 1 ). Figure 1 Mitotic events in E1A-reactivated myotubes. Myotubes derived from primary mouse satellite cells were infected with dl520 and subjected to immunofluorescence for MHC (a,c), stained with Hoechst 33258 (b,d,f), or photographed in phase contrast (e). Top panels: a MHC-positive myotube (a) shows an orderly progression of mitotic stages. The leftmost nucleus in (b), only partially included in the picture, is in interphase; the next one, (open triangle) in prophase; the next one in prometaphase; the next one (closed triangle) in metaphase; the next two are daughter nuclei in anaphase. Notice that no cleavage furrow is visible in (a). Middle panels: a MHC-positive myotube (c) shows multiple cleavage furrows enclosing mitotic nuclei. The size of the two largest nuclear masses in (d) suggests that they result from the coalescence of multiple nuclei. Bottom panels: part of a large, mitotic myotube is shown in (e), while (f) is the corresponding Hoechst 33258 staining. The four triangles in (e) indicate, from left to right: an area with several mitotic nuclei; a tripolar anaphase; a cleavage furrow not corresponding to any mitotic nuclei; a cleavage furrow separating two nuclear masses (f) presumably derived from the fusion of multiple nuclei
E1A-reactivated myotubes undergo multiple cell cycles
A question not directly addressed in our previous studies is whether E1A can induce TD myotubes to go through more than one cell cycle. To answer this question, we performed cell cycle analyses of TD muscle cells at different times after infection with the mutant dl520 adenovirus. Since myotubes, which possess variable numbers of nuclei, cannot be analyzed by cytofluorimetry, for these studies we used primary myocytes derived from murine satellite cells (MSC). TD, mononucleated myocytes were obtained by sparsely seeding MSC before induction of differentiation, so as to prevent fusion of the majority of them. Undifferentiated myoblasts that might have altered the results of the analyses were eliminated by b-D-arabinofuranoside (Ara-C) treatment. Figure 3 shows a time-course analysis of an experiment in which 68% of the myocytes were reactivated by dl520 infection, as determined by 5-bromo-2'-deoxyuridine (BrdUrd) staining. DNA synthesis began at approximately 36 h post infection (PI) and was fully under way at 42 h. The first cell cycle was essentially complete at 48 h PI, when most of the reactivated cells were in G2/M phase or had already entered the G1 phase of the second cycle. By 54 h PI, a second S-phase was evidently taking place, with a relevant fraction of the cells reaching G2/M phase for the second time by 72 h. Indeed, at this time a significant number of octaploid cells appeared, presumably being the result of DNA replication followed by ineffective cell division. Between 72 and 86 h PI, the reactivated cells began to die, giving raise to a hypodiploid peak, reminiscent of apoptosis. At 130 h PI, the peaks of DNA content unambiguously corresponding to reactivated cells (the tetra-and octaploid peaks) contained fewer cells than at earlier times, suggesting that most reactivated cells had died. As expected, the cell cycle profiles of myotubes infected with the control dl312 virus or mockinfected did not change throughout the experiment.
To confirm that E1A-reactivated muscle cells can go through more than one cell cycle, we used the previously described C2(E1A-ER) cells. 12 These cells are a clone of the C2C12 myoblast cell line stably expressing an estrogen-inducible E1A/estrogen-receptor chimera. C2(E1A-ER) myoblasts were induced to differentiate in the absence of estrogen and in the presence of Ara-C. When the derived myotubes were exposed to estrogen, about 80% of them incorporated BrdUrd as assessed by immunofluorescence staining (see Materials and Methods). Time-course analysis of BrdUrd incorporation showed that the first DNA synthesis took place entirely between 10 and 36 h after estrogen addition ( 12 and data not shown). Thus, to demonstrate that the C2(E1A-ER) cells could undergo a second cell cycle, we incubated the estrogen-reactivated Figure 2 Time-lapse videomicroscopy of a dividing myotube. Myotubes derived from quail embryo myoblasts were infected with dl520 and subjected to videomicroscopy; selected frames are shown and time elapsed from infection (hours : minutes) is indicated. A branch of a large myotube, initially relatively flat (first frame from top) begins to bulge as it enters mitosis (second and third frames). In the fourth frame, a section of the myotube including one of the nuclei rounds up and becomes highly refringent in phase contrast (indicated by a triangle). In the fifth frame, a second nucleus also rounds up, about 70 s after the first one. The sixth frame shows that, upon exit from mitosis, the resulting myotube fragments spread again onto the substrate. The original myotube branch is now divided into three segments. Presumably, the middle segment contains one of the daughter nuclei derived from the division of each of the two parental nuclei
Cell Death and Differentiation
Cell cycle reactivation in skeletal muscle cells L Latella et al myotubes with BrdUrd between 6 and 40 h or 40 and 53 h from estrogen induction. During the first 40 h, 82% of the myotubes incorporated BrdUrd, while 64% of them synthesized DNA during the second, shorter interval. These results indicated that at least 3/4 of the myotubes that had been initially reactivated went through a second Sphase. To show that BrdUrd incorporation during the second interval was not ascribable to an indefinitely protracted S-phase, identical dishes of C2(E1A-ER) myotubes were induced with estrogen and subjected to serial, 6-h pulses of BrdUrd. Figure 4 shows that BrdUrd incorporation occurred in two distinct phases, with peaks at 30 and 48 h from the beginning of estradiol induction, separated by a distinct`minimum' at 42 h. We conclude Figure 3 Cytofluorimetric cell cycle analysis of TD myocytes. Cultures of mononucleated myocytes derived from primary MSC were infected with the E1A-expressing dl520 virus, the control dl312 mutant, or mock-infected and analyzed at the indicated times after infection 
E1A-mediated reactivation of TD muscle cells leads to eventual cell death
In myotube cultures reactivated by E1A, cell death follows reactivation about 4 days after dl520 infection. To investigate the nature of such death, we analyzed reactivated myocytes by cytofluorimetry. A logarithmic scale for DNA content was chosen, which emphasizes the presence of a hypodiploid DNA peak, typical of apoptotic cell death ( Figure 5 ). At 96 h PI, control dl312-infected myocytes showed a relatively modest hypodiploid peak. In contrast, such peak represented more than two thirds of the dl520-reactivated myocytes.
To confirm that the reactivated muscle cells undergo apoptosis, dl520-and control-infected myotubes were subjected to TUNEL analysis. Figure 6 shows cytocentrifuge preparations of infected myotubes stained with the TUNEL method. Myotubes infected with the dl520 virus became weakly positive at 48 h PI. Massive, TUNELpositive cell death took place by 96 h PI, consistent with the cytofluorimetric results presented in Figure 3 . Thus, we conclude that E1A-mediated cell cycle reactivation of TD muscle cells leads to apoptotic cell death within 4 ± 5 days PI.
In an initial attempt at preventing apoptosis, we introduced into the C2Q7.2 subclone of C2C12 cells the 55 kDa product of the antiapoptotic adenovirus oncogene E1B, which binds and inactivates the cellular factor p53. One clone, C2Q7.2(CMVE1B55), which constitutively expresses E1B 55 kDa, was isolated (see Materials and Methods for details). Myotubes derived from this clone or the parental cells were infected with dl520 at an MOI of 60, which reactivated about 50% of the differentiated cells. The infected myotubes were TUNEL stained at 120 h PI. At this time, most parental cells were TUNEL-positive, while the E1B-expressing cells were almost entirely negative ( Figure  7 ).
To determine whether in these cells resistance to apoptosis is associated with prolonged survival, dl520-infected C2Q7.2(CMVE1B55K) myocytes were followed by time-lapse videomicroscopy. Remarkably, the cells survived up to 7 days after infection and underwent up to three mitoses (data not shown). However, even these partially resistant cells eventually died by apoptosis, as indicated by TUNEL staining at 7 days PI (data not shown).
E1A is not required to sustain the reactivated cell cycle in myotubes
Since the cell cycle is believed to be directed by sequential events that regulate one another, we conjectured that E1A might be needed in TD cells only for cell cycle initiation, but not for its maintenance. To test this hypothesis, we exploited again the C2(E1A-ER) myoblasts. About 80% of the myotubes derived from these cells can be reactivated by the continuous presence of 1 mM b-estradiol. We determined the shortest pulse of b-estradiol still sufficient to reactivate a significant fraction of the cells. It was found that a pulse as short as 6 h, followed by extensive washes, could induce DNA synthesis in about 30% of the myotubes. In this setting, Figure 4 Time-course analysis of BrdU incorporation in C2(E1A-ER) myotubes. Parallel dishes of C2(E1A-ER) myotubes were stimulated with 1 mM b-estradiol, pulsed with BrdUrd at 6 h intervals, and double-stained for MHC and BrdUrd (see Materials and Methods). Labels on the abscissa refer to the end of each consecutive 6-h interval (e.g., 18 indicates the 12 ± 18 h interval) Figure 5 Hypodiploid peaks of DNA content in adenovirus-infected myocytes. MSC-derived myocytes were infected with the dl312 or dl520 virus and analyzed by flow cytometry at 96 h PI. A relatively small hypodiploid peak, marked by a closed triangle, is visible in dl312-infected myocytes, and it is greatly enhanced in the dl520 cells
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Cell cycle reactivation in skeletal muscle cells L Latella et al S-phase starts no earlier than 10 h after the beginning of the estrogen pulse and at least 4 h after its end. 12 After 24 h from the beginning of stimulation, mitotic figures began to appear, demonstrating continuation of the cell cycle in the absence of b-estradiol. To determine whether the pulse-reactivated myotubes proceeded into a second cell cycle, we subjected them to BrdUrd pulse labeling. Replica dishes of C2(E1A-ER) myotubes stimulated from 0 to 6 h with b-estradiol were incubated with BrdUrd from 6 to 40 h or from 40 to 53 h. The intervals were chosen considering that there is no increase in the percentage of BrdUrd-positive cells after 36 h from the beginning of estrogen stimulation (data not shown). This indicates that the first S-phase is completed by 36 h and that BrdUrd incorporation occurring after that time is the result of Table 1 compares C2(E1A-ER) myotubes continuously stimulated with b-estradiol with those pulsed for only 6 h. In both instances, the majority of the cells labeled in the first interval underwent a second round of DNA replication between 40 and 53 h. These data show that continuous estradiol stimulation, presumptively corresponding to E1A activation, is not necessary for cell cycle progression. In an experiment similar to that shown in Figure  4 , BrdUrd incorporation was assessed at 6-h intervals in C2(E1A-ER) myotubes stimulated with estradiol for 6 h. The myotubes incorporated BrdUrd in two phases that peaked at 30 and 554 h from the beginning of estradiol induction (Figure 8a ). The two phases were separated by a gap at 42 h. The first peak of BrdU incorporation and the gap occurred at time points closely matching those of continuously stimulated myotubes, while the second incorporation phase was somewhat more extended in time. Again, we conclude that the two incorporation peaks represent two, separate S-phases belonging to successive cell cycles. To verify that estrogen withdrawal indeed causes complete E1A inactivation, we exploited differentiation as an indicator of E1A activity. Skeletal muscle differentiation is a cellular competence exquisitely sensitive to the activity of virtually all defined E1A functional domains. 11,13 ± 16 We reasoned that if any residual E1A activity were left after estradiol removal, it would significantly impair differentiation of myoblasts transiently stimulated with estrogen. Three identical cultures of undifferentiated C2(E1A-ER) myoblasts were induced to differentiate after diverse treatments. One culture was continuously treated with b-estradiol for 11 h in growth medium; differentiation was induced thereafter with serum-free medium containing b-estradiol. A second culture was stimulated with estradiol for 6 h and then washed free of estrogen for 5 h before inducing differentiation in the absence of estrogen. Finally, a third cell population was not stimulated with b-estradiol before or after inducing differentiation. The cultures were evaluated 4 days after induction of differentiation. As expected, cells constitutively treated with b-estradiol did not survive serum-free induction, presumably dying by E1A-triggered apoptosis. The extent of differentiation in the two surviving cell populations was then compared. The number of myosin heavy chain (MHC)-expressing (differentiated) cells was similar: by immunofluorescence, the pulse-treated and the untreated cultures showed 2.06 and 2.75 MHC-positive cells per highpower microscopic field, respectively. To eliminate the possible influence of cell death in the assessment of differentiation, we determined by Western blotting the total amount of MHC expressed by the two cultures, including the floating, dead cells. If residual E1A activity caused cell death or otherwise prevented differentiation of transiently- Figure 7 Expression of E1B 55 kDa affords partial protection from dl520-induced apoptosis. Myotubes derived from the C2Q7.2(CMVE1B55) clone and the parental C2Q7.2 cells were infected with dl520. Cytospin preparations were TUNEL stained at 120 h PI. At this time, the parental cells were mostly TUNEL-positive, while the E1B-expressing cells remained essentially negative Cell Death and Differentiation
Cell cycle reactivation in skeletal muscle cells L Latella et al stimulated myoblasts, this should result in a reduction in the total MHC expressed by the entire cell population. On the contrary, the transiently stimulated and the untreated cell cultures expressed identical amounts of MHC (Figure 8b ), suggesting that E1A is functionally silent already 5 h after b-estradiol withdrawal.
To test the reversibility of E1A-ER activation in myotubes, rather than myoblasts, we verified the effects of estrogen stimulation and withdrawal on the expression of an early differentiation marker, myogenin, by C2(E1A-ER) myotubes. Identical dishes of Ara-C-purified C2(E1A-ER) myotubes were either continuously stimulated or pulsed for 6 h with estrogen, washed, and maintained in estrogen-free medium. Dishes from both series were stained for myogenin and MHC by double, indirect immunofluorescence at 9, 24 and 36 h from the beginning of estradiol treatment. At time 0, 88% of the unstimulated myotubes were myogenin-positive. As shown in Figure 8c , myogenin-positive myotubes dropped to about 30% in both cultures at 9 h. However, while the percentage of myogenin-positive myotubes continued to decline with time in the chronically stimulated cultures, the fall halted and then reverted in pulse-treated myotubes. Thus, the effects of E1A activation can be reversed in myotubes, at least as judged by the influence of the oncogene on myogenin expression.
Taken together, the above experiments lead to the conclusion that, in all likelihood, the functional presence of E1A is only required to initiate proliferation in TD myotubes and is no longer necessary to complete the first cell cycle or to initiate a second one.
Discussion
We have previously shown that adenovirus E1A can reactivate the cell cycle in TD myotubes and adipocytes 6 and have investigated in depth the mode of action of the oncogene. 11 Our preferred experimental system, the skeletal muscle, has thus shown to be well suited for basic investigations of cell cycle-related events. However, in order to use muscle cells to explore the possibility of applying cell cycle reactivation to therapy, it is fundamental to assess the long-term fate of the reactivated cells. In this paper we describe and characterize the outcome of mitotic cycle reactivation in TD myotubes.
We show here that mitoses occur in E1A-transduced myotubes, following at least the first S-phase. However, in most polynucleated myotubes, mitoses are grossly aberrant. Since many nuclei share the same cytoplasm, mitotic spindles often connect chromosomes belonging to more than one nucleus resulting, after caryokinesis, in newly formed nuclei of extremely variable DNA and chromosome content (Figure 1 and M Crescenzi, unpublished observations). In addition, cleavage furrows are often misplaced in the myotubes, falling between two independently occurring nuclear divisions, rather than two daughter nuclei ( Figure  1e,f) , as already found in other polynucleated cells. 17 Nevertheless, small, polynucleated myotubes occasionally do divide successfully 9 as ordinarily do mononucleated myocytes. 6 Anyhow, problems deriving from the presence We report here that apoptotic cell death virtually invariably follows E1A-mediated reactivation of myotubes, as recently described for SV40 Large T-antigen. 18 In principle, there might be two alternative explanations for such outcome. On one hand E1A, a known apoptosis inducer, might extrinsically trigger cellular suicide mechanisms while reactivating the cell cycle. Alternatively, apoptosis might be the intrinsic result of damage occurring as a consequence of inappropriate cell cycle reentry by a TD cell. In the first case, cell death should be avoidable by interfering with the cellular apoptotic cascade. In the second scenario, cell death would be the insuppressible effect of physical cellular damage. At this time, the first hypothesis appears more plausible, since E1B 55 kDa is able to delay apoptosis significantly and allow more cell cycles to occur. The eventual occurrence of apoptosis even in E1B 55 kDa-expressing cells is not surprising in light of the fact that this protein is believed to prevent only p53-dependent programmed cell death. 19 Further studies are clearly necessary to determine the causes of apoptosis in reactivated TD cells and to find practical means to suppress this outcome.
The question of whether the reactivated muscle cells can undergo more than one cell cycle has been addressed in two, complementary ways. Cytofluorimetric evaluation of dl520-reactivated myocytes and analysis of C2(E1A-ER) myotubes concordantly lead to the conclusion that E1A-reactivated muscle cells go through at least two cell cycles, a demonstration that, to our knowledge, has not been provided in any other TD system. 18 If cell cycle reactivation of TD cells is to be exploited for therapeutic purposes it would be desirable to eventually rid the reactivated cells of the exogenous, cell cyclestimulatory gene. Using adenoviruses as transducing agents makes this purge automatic, since these viruses do not integrate their DNA into that of their hosts. Thus, in dividing cells, replication-defective adenoviral genomes are progressively diluted and eventually lost. E1A-ER pulseactivation experiments indicate that E1A is only necessary to commence the cell cycle. Once initiated, proliferation then continues as a self-maintained cellular function, dependent only on the presence of serum factors. 6 This conclusion requires the demonstration that full inactivation of E1A-ER can be achieved. We attempted to address this point in two ways. We showed that transient activation of E1A-ER in myoblasts, followed by a 5-h inactivation in the absence of estrogen, does not detectably affect the ability of myoblasts to differentiate immediately thereafter. Since this experiment involved E1A inactivation in myoblasts, its conclusions apply to the E1A-ER chimera itself, but not necessarily to the myotube intracellular environment. To verify that the chimeric molecule can be inactivated in the relevant cellular context, C2(E1A-ER) myotubes were transiently treated with b-estradiol. Myogenin protein expression, initially swiftly suppressed, recovered significantly upon estrogen withdrawal. It should be stressed that both myoblast differentiation 11,13 ± 16 and myogenin expression 11 have been shown to be strongly suppressed by essentially all identified E1A functional domains. In consequence, these experiments suggest that all E1A functions are reversible in C2(E1A-ER) myotubes. It is nonetheless conceivable that the cell cycle is sustained, in pulse-activated myotubes, by some persistent E1A activity. Any such residual activity would exert little or no influence on myoblast differentiation and myogenin expression. It would also be unable, per se, to start the cell cycle, since the percentage of reactivated myotubes is much smaller in pulse-activated than in chronically stimulated cultures (Table 1) . Although we cannot formally rule out this possibility, we regard it as unlikely.
Materials and Methods

Cells and viruses
The murine C2C12 myoblast line 20,21 was cultured as previously described. 11 Differentiation was induced by starving the cells in serum-free (SF) medium. Where indicated, 50 mM Ara-C was added to SF medium to eliminate undifferentiated cells. Within 72 h, Ara-Cpurified myotubes contained more than 90% of the nuclei in the culture. The C2Q7.2 clone of C2C12 cells was chosen among a number of randomly isolated ones for its better differentiation efficiency in comparison with C2C12 parental cells. C2Q7.2 cells were transfected with the pCMV-55K plasmid (kind gift of A Zantema). Stable transfectants were selected with G418 and screened by Western blotting; one clone expressing high levels of 55 kDa E1B was selected for further studies. Primary MSC and quail embryo myoblasts were isolated and cultured as described. 12, 22 Unless otherwise stated, all experiments involving expression of E1A in differentiated muscle cells were performed in medium containing 5 ± 7% fetal bovine serum to promote mitosis and prevent early death. 6 The dl520 mutant adenovirus expresses the 12S, but not the 13S E1A mRNA. The dl312 mutant does not express E1A. These mutants and the amplification and titration protocols have been described. 11 
Antibodies and immuno¯uorescence
Antibodies used: monoclonal antibody to BrdUrd (DAKO); rabbit antiserum (G Salvatori and G Cossu) or monoclonal antibody MF20 23 to MHC; monoclonal antibody F5D to myogenin 24 (kindly provided by G Cossu). Antisera to mouse or rabbit immunoglobulins were from ICN-Cappel. Immunofluorescence assays were performed by fixing the cells directly in the culture vessels and staining them in situ.
BrdUrd incorporation in differentiated muscle cells was assessed by double-immunofluorescence staining for BrdUrd and MHC. Only MHC-positive cells possessing 52 nuclei were scored. In the vast majority of cases, even in experiments with 6-h BrdUrd pulses, all of the nuclei in a single myotube were concordantly labeled or unlabeled. Rare myotubes displaying discordant nuclei were scored as positive if at least two contiguous nuclei were BrdUrd-positive (usually lightly labeled, having been fixed at the beginning of S-phase). Myogenin expression in MHC-positive cells was determined as above, with the antibody to myogenin replacing that to BrdUrd. All nuclei within a single myotube were always concordant with regard to myogenin expression. In all immunofluorescence procedures, nuclei were counterstained with Hoechst 33258.
TUNEL staining and Western blotting
Diluted supernatant from an MF20 hybridoma culture was used to detect MHC by Western analysis. Blots were developed using the ECL
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Cell cycle reactivation in skeletal muscle cells L Latella et al kit (Amersham). TUNEL assays were performed on cytocentrifuge slides. Infected myotubes were detached with trypsin at the appropriate time and counted. Approximately 20 000 myotubes were cytocentrifuged onto a microscope slide, allowed to dry, fixed in 4% buffered formaldehyde, permeabilized in 0.25% Triton X-100, and TUNEL stained using a commercial kit (Oncor).
Cyto¯uorimetry
For cell cycle analysis, Ara-C-purified myocytes were incubated overnight at 48C in phosphate-buffered saline containing 100 mg/ml propidium iodide, 200 mg/ml RNAse, and 0.2% Triton X-100 and analyzed with an EPICS XL cytofluorimeter (Coulter).
Time-lapse videomicroscopy
Ara-C-purified quail myotubes were prepared in a 25-cm 2 , tissue culture flask. The myotubes were infected with dl520 and maintained in SF medium for 24 h. The myotubes were then switched to medium containing 7% fetal bovine serum and 25 mM HEPES to stabilize pH in the absence of gas exchanges. The flask was then sealed and subjected to time-lapse, phase-contrast videomicroscopy on the heated stage of an inverted microscope.
